Donna Kersey

Donna Kersey
 

Lab Manager

dkersey@childrensmemorial.org

Children's Memorial Research Center
2430 N. Halsted St Room C303A
Chicago, IL 60614
Phone: (773) 755-6544

Education
  Year Degree Institution
    B.S. University of Kentucky

 

Work Experience 
  Period Description Organization
  July 2002 - Present lab manager Children's Memorial Hospital, Department of Pathology, Chicago, IL
  December 1990 - May 2002 lab manager Chicago Institute for Neurosurgery and Neuroresearch, Chicago, IL and Evanston, IL
  May 1990 - December 1990 research technologist II Northwestern University, Department of Pharmacology and The Cancer Center, Chicago, IL
  March 1989 - May 1990 research assistant Synergen, Department of Pharmaceutics, Boulder, CO
  September 1988 - March 1989 senior research analyst University of Kentucky, Department of Pathology and The Cancer Center, Lexington, KY
  October 1986 - September 1988 senior research analyst University of Kentucky, Department of Microbiology and Immunology and The Cancer Center, Lexington, KY
  November 1981 - December 1984 lecturer and translator Technical University of Wroclaw, Department of Foreign Language, Wroclaw, Poland
  1980 - 1981 research analyst University of Kentucky, Department of Biochemistry and The Sanders-Brown Center on Aging, Lexington, KY
  1977 - 1980 principal laboratory technician University of Kentucky, Department of Chemistry, Lexington, KY

Lab Affiliations 
  Perlman Lab 

Recent Publications
  C. Cutcliffe, D. Kersey, C-C Huang, Y. Zeng, D. Walterhouse, E.J. Perlman for the Renal Tumor Committee of the Children's Oncology Group (2005). Clear cell sarcoma of the kidney: Up-regulation of neural markers with activation of the sonic hedgehog and Akt pathways. Clinical Cancer Research: Nov 15; 11(22):7986 - 7994.
(Download Adobe Acrobat PDF)
  Q. Yang, S. Liu, Y. Tian, C. Hasan, D. Kersey, H. Salwen, A. Chlenski, E. Perlman and S. Cohn (2004). Methylation-associated silencing of the heat shock protein 47 gene in human neuroblastoma. Cancer Research : July 1;64:4531-4538.
  R.A. Kroes, A. Jastrow, M.G. McLone, H. Yamamoto, P. Colley, D.S. Kersey, V.W. Yong, E. Mkrdichian, L. Cerullo, J. Leestma and J.R. Moskal (2000). The identification of novel therapeutic targets for the treatment of malignant brain tumors. Cancer Letters: Aug11;156 (2):191-198.
  A. Rebbaa, H. Yamamoto, T. Saito, E. Meuillet, P. Kim, D.S. Kersey, E.G. Bremer, N. Taniguchi and J. R. Moskal (1997). Gene transfection-mediated overexpression of beta1,4GlcNAc bisecting oligosaccharides in glioma cell line U373 MG inhibits EGF receptor function. Journal of Biological Chemistry : Apr 4; 272 (14):9275-.
  H. Yamamoto, T. Saito, Y. Kaneko, D. Kersey, V.W. Yong, E.G. Bremer, E. Mkrdichian, L. Cerullo, J. Leestma and J.R. Moskal (1997). Alpha2,3-sialyltransferase mRNA and alpha2,3-linked glycoprotein sialylation are increased in malignant gliomas . Brain Research : 755:175-179.
  Y. Kaneko, H. Yamamoto, D. Kersey, K. Colley, J. Leestma, and J. Moskal (1996). The expression of Galbeta1,4GlcNAc alpha2,6 sialyltransferase and alpha2,6-linked sialoglycoconjugates in human brain tumors. Acta Neuropathologica : 91:284-292.
  A. Rebbaa, J. Hurh, H. Yamamoto, D. Kersey and E. Bremer (1996). Ganglioside GM3 inhibition of EGF receptor mediated signal transduction. Glycobiology 6: 399-406. 
  H. Yamamoto, Y. Kaneko, D. VanderMeulen, D. Kersey, E. Mkrdichian, L. Cerullo, and J. Moskal (1995). The expression of CMP-NeuAc:Galbeta1,4 GlcNAc alpha2,6 sialyltransferase and glycoproteins bearing alpha2,6-linked sialic acids in human brain tumors. Glycoconjugate Journal : 12:848-856.  
  M. Turker, K. Duffin, A. Smith, G. Martin, A. Martin, D. DiMartino, and D. Kersey (1991). Multidrug resistance phenotype associated with selection of an aminopterin resistant dog kidney cell line. Pharmacogenetics : 1:149-160.

Back to the top of the page